EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The role of deubiquitinase USP33 in colorectal cancer tumorigenesis and its potential as a therapeutic target predictor

Yu Dai, Xinyu Luo, Heng Wu, Yajun Luo, Zijian Deng, Jiqiang Wu, Li Zhang, Jin Yan

Discover Oncology · 09.02.2026 · 17 (1)

DOI: 10.1007/s12672-026-04546-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Discover Oncology, online erschienen am 09.02.2026. Verfasst von Yu Dai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Affiliated Hospital of Southwest Medical University, Street Taiping No.25, region, Jiangyang, Luzhou, 646099, Sichuan, Ch…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Fund of China, the Youth of Sichuan Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deubiquitination(DUB) is a critical cellular process that regulates protein stability and functionality, playing essential roles in cell proliferation, migration, tumorigenesis, and various molecular signaling pathways. Within the DUB enzyme family, ubiquitin-specific protease 33 (USP33) is found to be aberrantly expressed in several cancers, including a significant reduction in colorectal cancer (CRC) tissues. The decreased expression of USP33 impairs its ability to inhibit CRC cell proliferation, migration, and invasion, potentially through its involvement in key signaling pathways such as the β-arrestin-dependent ERK pathway, Slit-Robo pathway, and Wnt/β-catenin pathway. This review highlights the interaction between USP33 and these signaling pathways, exploring its potential as a novel independent prognostic biomarker for CRC and its promise as a therapeutic target.

Schlagwörter

Stichwörter der Autor:innen

Colorectal cancerSlit-RoboUSP33Wnt/β-cateninΒ-arrestin-dependent ERK

Autor:innen und Institutionen

  • Department of Oncology, The Affiliated Hospital of Southwest Medical University, Street Taiping No.25, region, Jiangyang, Luzhou, 646099, Sichuan, China.
  • School of Medicine, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
  • Department of Spine Surgery, The Affiliated Hospital of Chengdu Sport University, Chengdu, 610041, China.
  • Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, Street Taiping No.25, Region Jiangyang, Luzhou, 646099, Sichuan, China.
  • School of Medicine, Sichuan Cancer Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. zhangli@scszlyy.org.cn.
  • Department of Oncology, The Affiliated Hospital of Southwest Medical University, Street Taiping No.25, region, Jiangyang, Luzhou, 646099, Sichuan, China. yanjin_1111@163.com.

Förderung

  • the National Natural Science Fund of China
  • the Youth of Sichuan Science and Technology Program

Zitieren

APA

Dai, Y., Luo, X., Wu, H., Luo, Y., Deng, Z., Wu, J., Zhang, L., & Yan, J. (2026). The role of deubiquitinase USP33 in colorectal cancer tumorigenesis and its potential as a therapeutic target predictor. Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-04546-8

Vancouver

Dai Y, Luo X, Wu H, Luo Y, Deng Z, Wu J, et al. The role of deubiquitinase USP33 in colorectal cancer tumorigenesis and its potential as a therapeutic target predictor. Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-04546-8

BibTeX
@article{Dai2026,
  author = {Dai, Yu and Luo, Xinyu and Wu, Heng and Luo, Yajun and Deng, Zijian and Wu, Jiqiang and Zhang, Li and Yan, Jin},
  title = {The role of deubiquitinase USP33 in colorectal cancer tumorigenesis and its potential as a therapeutic target predictor},
  journal = {Discover Oncology},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.1007/s12672-026-04546-8}
}
Kostenlos starten →